Cost-benefit analysis of the FDA : the case of the Prescription Drug User Fee Acts
Year of publication: |
[2007]
|
---|---|
Authors: | Philipson, Tomas J. ; Berndt, Ernst R. ; Gottschalk, Adrian H. B. ; Sun, Eric |
Publisher: |
Chicago, Ill. : Univ. of Chicago, George J. Stigler Center for the Study of the Economy and the State |
Subject: | Arzneimittel | Pharmaceuticals | Kosten-Nutzen-Analyse | Cost-benefit analysis | Arzneimittelrecht | Pharmaceutical law | Aufsichtsbehörde | Regulatory agency | Wohlfahrtsanalyse | Welfare analysis |
-
Cost-benefit analysis of the FDA : the case of the prescription drug user fee acts
Philipson, Tomas J., (2008)
-
Assessing the safety and efficacy of the FDA : the case of the prescription drug user fee acts
Philipson, Tomas J., (2005)
-
Assessing the Safety and Efficacy of the FDA : The Case of the Prescription Drug User Fee Acts
Philipson, Tomas J., (2005)
- More ...
-
Cost-Benefit Analysis of the FDA: The Case of the Prescription Drug User Fee Acts
Philipson, Tomas J., (2007)
-
Cost-benefit analysis of the FDA : the case of the prescription drug user fee acts
Philipson, Tomas J., (2008)
-
Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process
Berndt, Ernst R., (2004)
- More ...